New Releases from NCBI BookshelfBaricitinib (Olumiant): Indication: For the treatment of adult patients with severe alopecia areata: CADTH Reimbursement Recommendation [Internet].Baricitinib (Olumiant): Indication: For the treatment of adult patients with severe alopecia areata: CADTH Reimbursement Recommendation [Internet].
CADTH recommends that Olumiant be reimbursed by public drug plans for the treatment of adults with severe alopecia areata (AA) […]
